Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt.
| Image |  |
|---|---|
| Description | scientific article published on 17 April 2018 |
| Author/s |
author: Gamal E. Shiha Wael Abdel-Razek Mohamed Hassany Imam Waked |
| Publication date | April 17, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |